[肺癌具有罕见的致癌驱动因素:RET,ROS-1,MET,HER2和BRAF]
Clara Morin1, Julien Mazières1
1Service de pneumologie, hôpital Larrey, CHU de Toulouse, Toulouse, France; Université Paul-Sabatier, Toulouse, France; Centre de recherche de cancérologie de Toulouse (CRCT), Inserm, Toulouse, France.
Bulletin du cancer
|March 28, 2025
概括
向疗法为非小细胞肺癌 (NSCLC) 提供有效的治疗,这些癌症的罕见驱动因素包括ROS-1,RET,MET,BRAF和HER2. 对这些司机的查确保了最佳的个性化药物和治疗选择.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 经常出现瘤原体驱动因素.
- 越来越多地发现罕见的致癌驱动因素 (发病率<5%),包括ROS-1/RET重组和MET/BRAF/HER2突变.
- 向疗法在NSCLC中表现出优异的瘤反应和耐受性,而不是化疗.
研究的目的:
- 审查目前针对NSCLC罕见的瘤原因驱动物的向疗法.
- 讨论针对这些特定遗传变化的新兴治疗分子.
- 强调全面的司机查在NSCLC个性化医学的重要性.
主要方法:
- 针对性疗法和NSCLC的瘤原因驱动因素的文献综述.
- 对罕见驱动突变的治疗疗效和安全数据的分析.
- 讨论法国现有的治疗策略和未来的前景.
主要成果:
- 向疗法在NSCLC中显示出显著的疗效,具有致癌驱动因素,往往优于化疗.
- 当有致癌驱动因素存在时,免疫检查点抑制剂的有效性可能会降低.
- 针对性疗法被确立为ROS-1/RET变异的第一线治疗方法,以及MET/BRAF突变的第二线治疗方法.
结论:
- 综合查瘤驱动因素,包括罕见的驱动因素,在诊断时对于有效的NSCLC管理至关重要.
- 向疗法是个性化医学的基石,革命性的NSCLC治疗.
- 对新型分子的持续研究有望为患有罕见瘤驱动因素的患者带来进一步的进展.
更多相关视频
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.9K
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
10.1K
相关概念视频
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...